Skip to main content
. 2021 Feb;10(2):790–801. doi: 10.21037/tlcr-20-1020

Figure 1.

Figure 1

Flow chart of study. Of the 449 non-small cell lung cancer (NSCLC) patients, 304 patients harbored activating epidermal growth factor receptor (EGFR) mutation were included in the final analysis.